246 related articles for article (PubMed ID: 36380646)
21. Evaluation of
Takazono T; Ito Y; Tashiro M; Nishimura K; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Yanagihara K; Mukae H; Izumikawa K
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842231
[TBL] [Abstract][Full Text] [Related]
22. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
[TBL] [Abstract][Full Text] [Related]
23. Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study.
Autier B; Prattes J; White PL; Valerio M; Machado M; Price J; Egger M; Gangneux JP; Hoenigl M
J Clin Microbiol; 2022 Jan; 60(1):e0168921. PubMed ID: 34643415
[TBL] [Abstract][Full Text] [Related]
24. Prospective and systematic screening for invasive aspergillosis in the ICU during the COVID-19 pandemic, a proof of principle for future pandemics.
van Grootveld R; van Paassen J; Claas ECJ; Heerdink L; Kuijper EJ; de Boer MGJ; van der Beek MT;
Med Mycol; 2024 May; 62(5):. PubMed ID: 38544330
[TBL] [Abstract][Full Text] [Related]
25. Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience.
Serin I; Baltali S; Cinli TA; Goze H; Demir B; Yokus O
BMC Infect Dis; 2022 Nov; 22(1):822. PubMed ID: 36348480
[TBL] [Abstract][Full Text] [Related]
26. [COVID-19-associated pulmonary aspergillosis in critically ill patients: experience of a Chilean public hospital].
Araya-Rojas F; Lasso-Barreto M
Rev Chilena Infectol; 2021 Dec; 38(6):754-760. PubMed ID: 35506848
[TBL] [Abstract][Full Text] [Related]
27. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
[TBL] [Abstract][Full Text] [Related]
28. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
Sulahian A; Porcher R; Bergeron A; Touratier S; Raffoux E; Menotti J; Derouin F; Ribaud P
J Clin Microbiol; 2014 Jul; 52(7):2328-33. PubMed ID: 24740084
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.
Urabe N; Sakamoto S; Sano G; Suzuki J; Hebisawa A; Nakamura Y; Koyama K; Ishii Y; Tateda K; Homma S
J Clin Microbiol; 2017 Jun; 55(6):1738-1746. PubMed ID: 28330887
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic performance of serum galactomannan and β-D-glucan for invasive aspergillosis in suspected patients: A meta-analysis.
Huang QY; Li PC; Yue JR
Medicine (Baltimore); 2024 Feb; 103(5):e37067. PubMed ID: 38306560
[TBL] [Abstract][Full Text] [Related]
32. Quantitative Real-Time PCR and Platelia Galactomannan Assay for the Diagnosis of Invasive Pulmonary Aspergillosis: Bronchoalveolar Lavage Fluid Performs Better Than Serum in Non-neutropaenic Patients.
Zhang S; Wang S; Wan Z; Que C; Li R; Yu J
Mycopathologia; 2016 Oct; 181(9-10):625-9. PubMed ID: 27270570
[TBL] [Abstract][Full Text] [Related]
33. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
[TBL] [Abstract][Full Text] [Related]
34. Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis - CAPA.
Cocio TA; Siqueira LPM; Riciluca KCT; Gimenes VMF; de Andrade TS; Benard G; Martínez R; Bollela VR
Braz J Infect Dis; 2023; 27(4):102793. PubMed ID: 37507102
[TBL] [Abstract][Full Text] [Related]
35. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
Danpornprasert P; Foongladda S; Tscheikuna J
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
[TBL] [Abstract][Full Text] [Related]
37. Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients.
Ergün M; Brüggemann RJM; Alanio A; Dellière S; van Arkel A; Bentvelsen RG; Rijpstra T; van der Sar-van der Brugge S; Lagrou K; Janssen NAF; Buil JB; van Dijk K; Melchers WJG; Reijers MHE; Schouten JA; Wauters J; Cordey A; Soni S; White PL; van de Veerdonk FL; Verweij PE
J Clin Microbiol; 2021 Nov; 59(12):e0122921. PubMed ID: 34495710
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
39. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics, bacterial coinfections and outcomes in COVID-19-associated pulmonary aspergillosis in a third-level Mexican hospital during the COVID-19 pre-vaccination era.
Hernández-Silva G; Corzo-León DE; Becerril-Vargas E; Peralta-Prado AB; Odalis RG; Morales-Villarreal F; Ríos-Ayala MA; Alonso TG; Agustín FD; Ramón AF; Hugo AV
Mycoses; 2024 Jan; 67(1):e13693. PubMed ID: 38214372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
